Gastrointestinal

Incorporating colo-rectal, pancreatic, cholangiocarcinomas (biliary tract) , primary liver cancers and neuroendocrine tumours

The Gastrointestinal (GI) Cancer Research Team is at the forefront of cancer research, leading the way to deliver better outcomes for our patients.

The GI team covers colorectal, pancreatic, cholangiocarcinomas (biliary tract), primary liver cancers and neuroendocrine tumours. We are made up of medical oncologists, clinical oncologists, a nuclear medicine clinician, clinical research fellows, clinical research nurses and clinical trial coordination staff.

The GI Research Team has a large portfolio of clinical trials for patients with GI cancers, many of which are in collaboration with our worldwide commercial partners. These include chemotherapy, radiotherapy, nuclear medicine and biological therapies. We also conduct research into therapies to control symptoms, as well as studying biomarkers (understanding cancer cells) to deliver a more personalised approach to the treatment of GI cancers.

We aim to provide personalised treatment for patients with GI cancers by further developing a clinical and translational research programme.  As our understanding of the molecular characteristics of cancers and tumour evolution advances, through early-phase clinical trials we will continue providing leadership in the development of targeted treatments, delivering personalised medicine tailored to the genetic profile of a patient’s tumour. 

We are determined to deliver national and international ‘firsts’ in GI cancer research and will focus on the delivery of cutting-edge scientific research, improving patient outcomes and quality of life. We strive to be at the forefront of GI cancer research globally and will continue providing clinical leadership for national, practice-changing clinical trials.

Team objectives

  • To guide and support patients through the complexity of treatment choices to ensure the best individualised treatment for the patient
  • To give every patient an opportunity to participate in clinical research during their cancer journey
  • To conduct an increased number of clinical trials using shared care arrangements with local district general hospitals to help patients access clinical trials nearer home

For more information about cancer screening and prevention, click here.

 


;